Web Date: May 8, 2007
Brazil Breaks Patent On A Merck Drug
Merck & Co. says it is "profoundly disappointed" by Brazil's decision to break the patent on a key AIDS drug made by the U.S. pharmaceutical giant and buy a less expensive generic version of the medicine from India.
On May 4, Brazilian President Luiz In??cio Lula da Silva signed a decree authorizing his country's Ministry of Health to issue a "compulsory license" for efavirenz, a move that allows a country . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society